Retour
Fourchette du Jour
24,03 €
24,64 €
Fourchette 52 Semaines
14,00 €
30,68 €
Volume
197 128
Moyenne 50J / 200J
27,16 €
/
21,03 €
Clôture Précédente
24,60 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -14,8 | 0,3 |
| P/B | 7,1 | 2,9 |
| ROE % | -70,1 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
45,67 €
+86.3%
Low: 36,00 €
High: 51,00 €
BPA Prévisionnel
-1,74 €
CA Est.
5,2 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,66 €
-0,58 € – 10,96 €
|
640 M | 2 |
| FY2029 |
0,73 €
-0,16 € – 3,00 €
|
330 M | 4 |
| FY2028 |
-1,14 €
-16,56 € – 26,93 €
|
120 M | 6 |
Points Clés
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -62,51M
PEG of 0,60 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-70,09%
ROIC-29,89%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,01
Current Ratio5,96
Interest Coverage-99,49
Valorisation
P/E Ratio
-14,83
P/B Ratio7,14
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -94,51M |
| ROE | -70,09% | ROA | -40,01% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -62,51M |
| ROIC | -29,89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 5,96 |
| Interest Coverage | -99,49 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -14,83 | P/B Ratio | 7,14 |
| P/S Ratio | N/A | PEG Ratio | 0,60 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,40B | Enterprise Value | 1,32B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 686 000,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -94,51M | -85,78M | -88,80M | -38,70M | -18,55M |
| EPS (Diluted) | -1,81 | -2,12 | -2,97 | -1,18 | -0,57 |
| Gross Profit | 0,0 | -51,40M | 0,0 | 0,0 | 0,0 |
| Operating Income | -79,15M | -73,20M | -80,71M | -32,38M | -13,23M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 236,23M | 120,35M | 114,35M | 37,06M | 58,04M |
| Total Liabilities | 39,94M | 46,97M | 20,63M | 135,05M | 119,00M |
| Shareholders' Equity | 196,29M | 73,38M | 93,73M | -97,99M | -60,96M |
| Total Debt | 2,32M | 1,18M | 605 000,0 | 123,08M | 114,27M |
| Cash & Equivalents | 81,42M | 27,71M | 38,33M | 19,79M | 46,28M |
| Current Assets | 219,14M | 104,90M | 101,02M | 23,66M | 47,98M |
| Current Liabilities | 36,79M | 44,24M | 19,09M | 12,02M | 4,06M |